BOSTON--(BUSINESS WIRE)--Click to Tweet this News
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for spasms associated with severe neuromuscular conditions, nocturnal leg cramps and exercise-associated muscle cramps, announced today that it will present at the 26th International Symposium on amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) in Orlando, FL on Saturday, December 12th at 6:40pm ET.
